It is also worth mentioning that all of the genes used in preMSIm are down-regulated in MSI, except RPL22L1, whereas the MAP signature additionally includes both up- and down-regulated genes in CRC. This evidence concerns the gene RPL22L1 and colorectal carcinoma.